Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study.

Autor: Yeung DT; Royal Adelaide Hospital, Adelaide, Australia., Shanmuganathan N; South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia., Reynolds J; Alfred Health and Monash University, Melbourne, VIC, Australia., Branford S; Centre for Cancer Biology, SA Pathology, Adelaide, Australia., Walia M; ALLG, Richmond, Australia., Yong AS; Royal Perth Hospital, Australia., Shortt J; Monash University, Clayton, Australia., Chee L; The Royal Melbourne Hospital/ Peter MacCallum Cancer Centre, Melbourne, Australia., Viiala N; Liverpool Hospital, Sydney, Australia., Cunningham I; Concord Hospital University of Sydney, Sydney, Australia., Ross DM; Flinders Medical CEntre, Australia., D'Souza AB; Wellington Regional Hospital, Wellington, New Zealand., Wright M; Fiona Stanley Hospital, Murdoch, Australia., Harrup RA; Royal Hobart Hospital, HOBART, Australia., Forsyth CJ; Gosford Hospital, North Gosford, Australia., Filshie R; St Vincent's Hospital, melbourne, Australia., Lane SW; Queensland Institute of Medical Research, Brisbane, Australia., Browett PJ; The University of Auckland, Auckland, New Zealand., Grove CS; Sir Charles Gairdner Hospital/PathWest, Nedlands, Australia., Grigg AA; Austin Hospital, Melbourne, Australia., Hughes TP; South Australian Health and Medical Research Institute, Adelaide, Australia.

Publikováno v: Blood [Blood] 2024 Aug 05. Date of Electronic Publication: 2024 Aug 05.